Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trails Edge Biotechnology Master Fund is a specialized investment vehicle managed by Trails Edge Capital, a New York-based investment firm. The fund focuses exclusively on the healthcare and life sciences sectors, providing capital to both public and private biotechnology companies. It employs a fundamental, research-driven investment strategy to identify innovative therapeutic platforms, medical devices, and healthcare services with high growth potential. By leveraging deep industry expertise, the fund aims to support companies developing transformative treatments for unmet medical needs. While the entity does not develop its own drug pipeline, it is a significant participant in the biotech financing ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trails Edge Biotechnology Master Fund.